Consent to the Distribution of a New Medicine Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto: Schedule Name and Strength Form Name and Address of Manufacturer Proprietary Name(if any) Carbidopa monohydrate 27 mg equivalent to 25 mg anhydrous carbidopa and levodopa 100 mg; carbidopa monohydrate 27 mg equivalent to 25 mg anhydrous carbidopa and levodopa 250 mg Tablets Apotex Inc., Weston, Ontario, Canada Apo-Levocarb Calcium carbonate 1337 mg equivalent to 500 mg elemental calcium Tablet, film coated Healtheries of New Zealand Limited, Mount Wellington, Auckland Osteo-500 Calcium carbonate 774 mg, magnesium carbonate 66.3 mg, magnesium trisilicate (hydrate) 44.2 mg Tablet, chewable Nestle (NZ) Limited, Waiuku Quick-Eze, Lemon Flavoured Morphine sulphate 50 mg Tablet, film coated Bard Pharmaceuticals Limited, Cambridge, England Sevredol Hepatitis A vaccine 720EU/mL, hepatitis B (rDNA) vaccine 20g/mL in 1 mL Injection, suspension, vial and syringe SmithKline Beecham Biologicals Manufacturing, Rixensart, Belgium Twinrix Adult Hepatitis A vaccine 720EU/mL, hepatitis B (rDNA) vaccine 20g/mL in 0.5 mL Injection, suspension, vial and syringe SmithKline Beecham Biologicals Manufacturing, Rixensart, Belgium Twinrix Junior Dated this 6th day of October 1998. G. R. BOYD, Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on the 20th day of February 1997.